Organisation: Position: Deadline Date: Location:


September 20th, 2017 Among postmenopausal women in the Women’s Health Initiative trials, use of hormone therapy (HRT) for five to seven years was not associated with risk of all-cause, cardiovascular or cancer death over 18 years of follow-up, according to a...

Weekly Roundup


Ibuprofen links to increased CVD risk in arthritis patients

Ibuprofen is associated with increased blood pressure and hypertension compared to celecoxib in patients with osteoarthritis or rheumatoid arthritis and increased risk of cardiovascular disease, according to late-breaking results from the... September 20th, 2017

Radio-frequency catheter ablation lowers mortality in AF patients

Researchers at the University of Utah Health and Klinikum Coburg, Germany co-led a clinical trial that showed radio-frequency catheter ablation lowered hospitalisation and mortality rates by 47% and 44% respectively in patients with atrial... September 20th, 2017

Slow walking a good predictor of heart-related death

Middle-aged people who report that they are slow walkers could be at higher risk of heart disease compared to the general population, researchers at the NIHR Leicester Biomedical Research Centre, UK – a partnership between Leicester's hospitals,... September 20th, 2017

Two-medicine regime after stenting safer than current regime

Using just two anticlotting medicines for patients who have atrial fibrillation and have had a stent placed in a heart artery is safer than using the current standard treatment of three medications, according to a study presented by Brigham and... September 20th, 2017


Close to a third of US diabetes patients delay insulin treatment

Although delaying insulin therapy leads to a worsening progression of diabetes, research by Brigham and Women's Hospital has found 30% of type 2 diabetic patients don't begin insulin when it's initially recommended, with the average start time being... September 20th, 2017


Smokers with HIV 10x more likely to die from lung cancer

People living with HIV who adhere to antiretroviral therapy but smoke cigarettes are around 10 times more likely to die from lung cancer than from HIV itself, according to a study led by researchers at Massachusetts General Hospital (MGH). The... September 20th, 2017


New rapid molecular test detects MDR-TB mutations

A new rapid molecular test has shown the ability to detect, with reasonable certainty, mutations associated with multidrug-resistant tuberculosis (MDR-TB), an international team of researchers have reported. In head-to-head comparisons against... September 20th, 2017

Anti-TB drug should be given to children, study says

An innovative anti-tuberculosis drug that represents a reprieve for adults whose disease does not respond to other treatments should also be made available to children aged 12 or older, according to findings from a study reported in the US Centres... September 20th, 2017


Different meats have different diabetes risk

While a plant-based diet is generally considered healthier than a meat-based diet in preventing the risk of diabetes, not all meats affect the risk equally. As Professor Koh Woon Puay, professor of clinical sciences at Duke-NUS Medical School... September 20th, 2017


Aspirin cuts colon cancer risk but may make it harder to treat

Daily aspirin use – known to reduce the risk of colon cancer – could also make the disease harder to treat if it does occur, a modelling study found. If confirmed statistically and in the lab, would mean that aspirin's ability to ward off... September 20th, 2017


Lay interventions effective against depression and harmful drinking

Brief psychological interventions delivered by lay counsellors in primary care were effective and cost-effective for patients with depression and harmful drinking in India, according to two studies by Vikram Patel of Harvard Medical School and... September 20th, 2017



Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.